141 related articles for article (PubMed ID: 6098328)
1. Prenatal haloperidol alters striatal dopamine and opiate receptors.
Moon SL
Brain Res; 1984 Dec; 323(1):109-13. PubMed ID: 6098328
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
Tecott LH; Kwong LL; Uhr S; Peroutka SJ
Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
[TBL] [Abstract][Full Text] [Related]
3. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
5. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure.
Schmidt MH; Lee T
Psychiatry Res; 1991 Mar; 36(3):319-28. PubMed ID: 1676523
[TBL] [Abstract][Full Text] [Related]
6. The effect of ethanol and haloperidol on dopamine receptor (D2) density.
Fuchs V; Coper H; Rommelspacher H
Neuropharmacology; 1987 Aug; 26(8):1231-3. PubMed ID: 3658125
[TBL] [Abstract][Full Text] [Related]
7. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Schweitzer JW; Schwartz R; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
[TBL] [Abstract][Full Text] [Related]
8. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
Morgan DG; Sinha YN; Finch CE
Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
10. Consequences of perinatal drug administration on brain development: striatal opiate receptors and dopamine.
Moon SL
NIDA Res Monogr; 1985; 62():129-45. PubMed ID: 3001526
[No Abstract] [Full Text] [Related]
11. Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol.
Liskowsky DR; Potter LT
Neuropharmacology; 1987 May; 26(5):481-3. PubMed ID: 2955242
[TBL] [Abstract][Full Text] [Related]
12. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
13. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
Koller WC
J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
[TBL] [Abstract][Full Text] [Related]
14. Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
Rosengarten H; Friedman E; Friedhoff AJ
Birth Defects Orig Artic Ser; 1983; 19(4):511-3. PubMed ID: 6871420
[No Abstract] [Full Text] [Related]
15. Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug.
Severson JA; Robinson HE; Simpson GM
Psychopharmacology (Berl); 1984; 84(1):115-9. PubMed ID: 6149590
[TBL] [Abstract][Full Text] [Related]
16. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
Prosser ES; Csernansky JG; Hollister LE
Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
[TBL] [Abstract][Full Text] [Related]
17. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
Simpson MD; Jenner P; Marsden CD
Biochem Pharmacol; 1986 Oct; 35(20):3501-6. PubMed ID: 3768037
[TBL] [Abstract][Full Text] [Related]
18. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Allen RM; Lane JD; Brauchi JT
Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
[TBL] [Abstract][Full Text] [Related]
19. Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment.
Agnati LF; Fuxe K; Benfenati F; Battistini N; Zini I; Toffano G
Neurosci Lett; 1983 Oct; 40(3):293-7. PubMed ID: 6646502
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
DeLucia R; Scavone C; Camillo MA
Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
